Navigation Links
Gladstone investigators discover how resting T cells avoid HIV infection

Scientists have discovered the mechanism that enables some CD4 T cells -- the main target of HIV -- to thwart the virus. The discovery, reported on April 13 in the online version of Nature, could open the door to an entirely new strategy for preventing the spread of HIV infection in the body's cells, according to the senior author of the study, Gladstone Institute of Virology and Immunology Director Warner C. Greene, MD, PhD.

The researchers, led by Ya-Lin Chiu, PhD, a postdoctoral fellow in the Greene lab, investigated why resting, nondividing CD4 T cells are impervious to HIV infection, while activated, dividing CD4 T cells are not. The team discovered that a potent antiviral factor called APOBEC3G (A3G) is the key.

The team, working in cell culture, found that A3G exists in two different-sized forms -- a small form that actively repels the virus, and a large form that is completely ineffective against it. Moreover, they detected only the small form in resting CD4 T cells, where HIV fails to grow, and only the large form in activated CD4 T cells, where the virus efficiently grows and wreaks havoc. They further showed that blocking production of the small, active form of A3G in resting CD4 T cells was sufficient to make these normally resistant resting cells highly susceptible to HIV infection.

"Until now, the prevailing belief has been that HIV failed to infect resting T-cells due to a simple lack of some essential factor or nutrient," says Greene, a professor of medicine, microbiology and immunology at the University of California, San Francisco. "This study now shifts the paradigm, showing that resting CD4 T cells actively repel HIV infection through the action of the small, enzymatically active form of A3G, which stops the virus in its tracks."

CD4 T cells are a class of lymphocytes, or white blood cells, that fight infection by orchestrating immune responses. They have the ability to recognize specific antigens -- foreign substan
'"/>

Source:UC San Francisco


Page: 1 2 3

Related biology news :

1. Gladstone investigators identify a new protective action for the powerful anti-HIV factor, APOBEC3G
2. MUHC investigators search for the root of sexual pain in women
3. UAB scientists discover the origin of a mysterious physical force
4. Researchers discover way to make cells in the eye sensitive to light
5. Protein discovery could unlock the secret to better TB treatment
6. Newly-discovered class of genes determines ?and restricts ?stem cell fate
7. Newly discovered virus linked to childhood lung disorders and Kawasaki disease
8. Purdue proves concept of using nano-materials for drug discovery
9. Scientists discover the cellular roots of graying hair
10. Researchers discover molecule that causes secondary stroke
11. Scientists discover unique microbe in Californias largest lake
Post Your Comments:
(Date:5/15/2013)... occurring "keystone" molecules that have powerful behavioral effects ... roles in structuring ecosystems, according to a theory ... . The authors of the theory, Ryan P. ... Zimmer of the University of California at Los ... or plants that may be uncommon but exert ...
(Date:5/15/2013)... Canada,s goal of reducing greenhouse gas (GHG) emissions to ... year 2020, federal and provincial governments, led by the ... what portion of the total GHG reduction will be ... of Toronto,s School of the Environment. Their report ... governments, opposition parties and other participants in the climate ...
(Date:5/15/2013)... of its strategic plan, " Forging the Future ... Energy Joint Genome Institute (DOE JGI) has positioned itself ... their users so that they can address pressing energy ... early step in this process is the launch of ... primary purpose of the ETOP is to develop and ...
Breaking Biology News(10 mins):Natural 'keystone molecules' punch over their weight in ecosystems 2Canada must addess real climate-change challenge 2Canada must addess real climate-change challenge 3The DOE Joint Genome Institute expands capabilities via new partnerships 2The DOE Joint Genome Institute expands capabilities via new partnerships 3
... French . , Montreal, April 8, 2009 ... its affiliated research centres has received a boost, thanks to ... the Government of Quebec and the private sector. The CFI ... the Universit de Montral, the Sainte-Justine University Hospital Research Center ...
... University are looking to soy as a way to make ... dog and less costly for the owners. Dr. Steven ... genistein - a molecule found in soy that has been ... cells in humans - to determine whether it would also ...
... new therapy for metastatic prostate cancer has shown considerable promise ... resistant to current drugs. , Of 30 men who ... phase I/II trial designed to evaluate safety, 22 showed a ... in their blood. Phase III clinical trials are planned to ...
Cached Biology News:CFI awards $854,098 to University of Montreal and partners 2CFI awards $854,098 to University of Montreal and partners 3New medications show promise in treating drug-resistant prostate cancer 2New medications show promise in treating drug-resistant prostate cancer 3New medications show promise in treating drug-resistant prostate cancer 4
(Date:5/17/2013)... release is available in German . ... well: with the naked eye, you can see which branch ... the blur of branches through the telephoto lens for high-magnification ... researchers who are looking to study proteins, the active biomolecules ... Zurich,s Institute for Molecular Systems Biology, and her colleagues have ...
(Date:5/17/2013)... , May 17, 2013  Cellular Biomedicine ... achieved 50% enrollment of the total projected enrollment ... the safety and preliminary efficacy of the medical ... for Knee Osteoarthritis (KOA). To date the trial ... The Phase I open label clinical ...
(Date:5/17/2013)... Toronto, Canada (PRWEB) May 17, 2013 ... to understanding complex biological systems that can help predict ... Keynote speaker Dr. Sergey Stepaniants, Head of Computational Biology ... of computational biology tools to ensure high-quality genomics when ... tools can be applied to complex data sets to ...
(Date:5/16/2013)... The Stirling Ultracold Model SU780U ... OH, USA, won the Outstanding New Product Award presented ... Biological and Environmental Repositories (ISBER) at their annual meeting ... annually, recognizes the company’s development and introduction of the ... award was presented to Global Cooling’s CEO Neill Lane ...
Breaking Biology Technology:Proteome atlas for the tuberculosis pathogen 2Proteome atlas for the tuberculosis pathogen 3Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Stirling Ultracold Ultra-Low Freezer Wins 2013 Outstanding New Product Award at International Biorepository Conference, Sydney, Australia 2
... Orexigen® Therapeutics, Inc. (Nasdaq: OREX ), today ... accepted for poster presentations and an oral presentation at ... Society. This meeting will be held October 1-5, 2011 ... Details on the presentation times are ...
... the UC Davis School of Medicine have outlined several ... is currently under scrutiny by the U.S. National Institutes ... Science Translational Medicine in a focus article titled, ... online at www.ScienceTranslationalMedicine.org . "In this ...
... Sciences International, Inc. (Nasdaq: BDSI ) announced ... 3 clinical study of BEMA Buprenorphine for the treatment ... opioid naive and opioid experienced population.  The primary endpoint ... Buprenorphine and placebo, was not achieved; however, BDSI believes ...
Cached Biology Technology:Orexigen® Therapeutics Announces Multiple Contrave® Data Presentations at the 29th Annual Scientific Meeting of The Obesity Society 2UC Davis advocates for new approaches to biomedical research 2UC Davis advocates for new approaches to biomedical research 3BioDelivery Sciences Announces Results from Phase 3 Efficacy Study for BEMA Buprenorphine in Chronic Pain 2BioDelivery Sciences Announces Results from Phase 3 Efficacy Study for BEMA Buprenorphine in Chronic Pain 3BioDelivery Sciences Announces Results from Phase 3 Efficacy Study for BEMA Buprenorphine in Chronic Pain 4BioDelivery Sciences Announces Results from Phase 3 Efficacy Study for BEMA Buprenorphine in Chronic Pain 5BioDelivery Sciences Announces Results from Phase 3 Efficacy Study for BEMA Buprenorphine in Chronic Pain 6
Applications: Immunohistochemistry, ISH, FISH, CISH....
Attachments: Clip bar for tubes 10 to 19 mm in diameter Overall Dimension Height IC: 6 (15.2) Overall Dimension Length IC: 18.5 (46.9) Overall Dimension Width IC: 4 (10.2)...
Request Info...
...
Biology Products: